DUBAI: The entry and approval of a new screening or test against cervical cancer is being discussed with Abu Dhabi health authorities, according to a Tawam Hospital senior official.
Meanwhile on Monday, the Zulekha Hospital Group (ZHG) launched the third edition of its “Smear Don’t Fear” campaign that aims at not only educating the community about preventions and treatments against the disease caused by the human papillomavirus (HPV) but more importantly conducting free cervical screenings with gynaecologist consultations until June 30, 2016.
From the launch, Dubai Health Authority-Health Regulation and Dubai Medical Tourism Project director Dr Layla Al Marzouki said, “We should aim for 100 per cent vaccination coverage in the UAE.”
The vaccination has been a Abu Dhabi public health policy since 2008.
The inoculations which come in three doses are recommended for girls from age nine and which may be taken until they are age 36 while for the boys are from ages nine and 21.
Direct from her clinic in California, Dr Pamela Munster who has been the ZHG spokesperson on cancer awareness programmes emphasised that boys must also be vaccinated because not doing so would not address the rising concerns about cervical cancer, mostly diagnosed among people with multiple partners.
On the new screening or test, Tawam Hospital-Obstetrics & Gynaecology Department chairman Dr Saad Ghazal told The Gulf Today, “We already started talks with the Health Authority Abu Dhabi. We had presented to them the difference between smear screening and the HPV screening which is more accurate.”
The gynaecologist-oncologist mentioned the HPV test when he was the lecturer at a recently-held Roche Diagnostics Middle East Media Talks.
Ghazal said the HPV test was approved by the US Food and Drug Administration in 2014 after a series of clinical trials in many parts of the world.